{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:03:16Z","timestamp":1791421396090,"version":"4.3.3"},"reference-count":135,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Pulmonary and Critical Care Medicine"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:p>Bronchiectasis-Chronic Obstructive Pulmonary Disease Overlap Syndrome (BCOS) is a complex pulmonary condition that merges bronchiectasis and chronic obstructive pulmonary disease (COPD), presenting unique clinical challenges. Patients with BCOS typically exhibit a range of symptoms from both conditions, including a chronic productive cough, reduced lung function, frequent exacerbations, and diminished exercise tolerance. The etiology of BCOS involves multiple factors such as genetic predisposition, respiratory infections, tobacco smoke, air pollutants, and other inflammatory mediators. Accurate diagnosis requires a comprehensive approach, incorporating pulmonary function tests to evaluate airflow limitation, radiographic imaging to identify structural lung abnormalities, and blood eosinophil counts to detect underlying inflammation. Treatment strategies are tailored to individual symptom profiles and severity, potentially including bronchodilators, inhaled corticosteroids, and pulmonary therapy to improve lung function and quality of life. Patients with BCOS are also at an increased risk for cardiovascular complications, such as stroke, ischemic heart disease, and cor pulmonale. Additionally, medications like beta-agonists and muscarinic antagonists used in COPD treatment can further affect cardiac risk by altering heart rate. This paper aims to provide a thorough understanding of BCOS, addressing its development, diagnosis, treatment, and associated cardiovascular complications, to aid healthcare providers in managing this multifaceted condition and improving patient outcomes.<\/jats:p>","DOI":"10.1177\/29768675241300808","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T03:36:50Z","timestamp":1733715410000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Bronchiectasis-COPD Overlap Syndrome: A Comprehensive Review of its Pathophysiology and Potential Cardiovascular Implications"],"prefix":"10.1177","volume":"19","author":[{"given":"Mohammad Ajaz","family":"Alam","sequence":"first","affiliation":[{"name":"Avalon University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4937-3629","authenticated-orcid":false,"given":"Padmavathi","family":"Mangapuram","sequence":"additional","affiliation":[{"name":"Avalon University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3341-7251","authenticated-orcid":false,"given":"Fremita Chelsea","family":"Fredrick","sequence":"additional","affiliation":[{"name":"Avalon University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupinder","family":"Singh","sequence":"additional","affiliation":[{"name":"NYC Health+Hospitals"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amishi","family":"Singla","sequence":"additional","affiliation":[{"name":"Dallastown Area High School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Kumar","sequence":"additional","affiliation":[{"name":"Fortis Escorts Heart Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9101-2351","authenticated-orcid":false,"given":"Rohit","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Penn State Health Milton S. Hershey Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,12,9]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-023-02217-0"},{"key":"e_1_3_3_3_2","unstructured":"World Health Organization: WHO. Chronic obstructive pulmonary disease (COPD). Accessed 14 June 2024. https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/chronic-obstructive-pulmonary-disease-(copd)"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00511-7"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2023.104174"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.106270"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201303-0411CI"},{"key":"e_1_3_3_8_2","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. 2024 GOLD report. Accessed 17 June 2024. https:\/\/goldcopd.org\/2024-gold-report\/"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2021.11.005"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra012519"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1515\/med-2022-0599"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-1758"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.3109\/15412555.2014.922174"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2018.05.008"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00170014"},{"key":"e_1_3_3_16_2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00328-2018","article-title":"The overlap between bronchiectasis and chronic airway diseases: State of the art and future directions","volume":"52","author":"Polverino E","year":"2018","unstructured":"Polverino E, Dimakou K, Hurst J, et al. The overlap between bronchiectasis and chronic airway diseases: State of the art and future directions. Eur Respir J. 2018;52(3). https:\/\/erj.ersjournals.com\/content\/52\/3\/1800328.short","journal-title":"Eur Respir J."},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/life13020444"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00003709"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2017.1305895"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.12.024"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.02.024"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01409"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150532"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2021.152667"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2022.153318"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113402"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008157"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2018.09.008"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2017-0200TR"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00183.2013"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S271810"},{"key":"e_1_3_3_32_2","unstructured":"NHLBI NIH. COPD - Alpha-1 antitrypsin deficiency. Published 2023. Accessed 20 June 2024. https:\/\/www.nhlbi.nih.gov\/health\/alpha-1-antitrypsin-deficiency#:\u223c:text=Alpha-1%20antitrypsin%20%28AAT%29%20deficiency%20increases%20an%20individual%E2%80%99s%20risk"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201911-2209ED"},{"key":"e_1_3_3_34_2","unstructured":"Insmed. Insmed announces positive topline results from landmark ASPEN study of brensocatib in patients with bronchiectasis. Accessed 20 June 2024. https:\/\/investor.insmed.com\/2024-05-28-Insmed-Announces-Positive-Topline-Results-from-Landmark-ASPEN-Study-of-Brensocatib-in-Patients-with-Bronchiectasis#:\u223c:text=As%20a%20DPP1%20inhibitor%2C%20brensocatib"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1910234"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13671"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1080\/15412555.2018.1476475"},{"key":"e_1_3_3_38_2","unstructured":"Wise R. Chronic Obstructive Pulmonary Disease (COPD). Merck Manuals Professional Edition. Merck Manuals; 2024. Alpha-1 Antitrypsin Deficiency - Pulmonary Disorders - Merck Manual Professional Edition (merckmanuals.com). https:\/\/www.merckmanuals.com\/en-ca\/professional\/pulmonary-disorders\/chronic-obstructive-pulmonary-disease-and-related-disorders\/alpha-1-antitrypsin-deficiency"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00028.2015"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2017.11.014"},{"key":"e_1_3_3_41_2","unstructured":"Meseeha M Attia M Sankari A. Alpha 1 antitrypsin deficiency. Accessed 10 July 2024. https:\/\/pubmed.ncbi.nlm.nih.gov\/28723059\/"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2012(11)19"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/all.13760"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S15417"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1177\/039463201402700205"},{"key":"e_1_3_3_46_2","article-title":"miR-4456\/CCL3\/CCR5 pathway in the pathogenesis of tight junction impairment in chronic obstructive pulmonary disease","volume":"12","author":"Yu W","year":"2021","unstructured":"Yu W, Ye T, Ding J, et al. miR-4456\/CCL3\/CCR5 pathway in the pathogenesis of tight junction impairment in chronic obstructive pulmonary disease. Front Pharmacol. 2021;12.","journal-title":"Front Pharmacol."},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01642-2015"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11030464"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02006-2016"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S366126"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201208-1518OC"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020523"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200305-648OC"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2021.1906225"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.3390\/toxins8080236"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0016-2018"},{"key":"e_1_3_3_57_2","unstructured":"Martin J. NTM lung disease: What it is and what you need to know. Published 2019. Accessed 27 June 2024. https:\/\/www.copdfoundation.org\/COPD360social\/Community\/COPD-Digest\/Article\/1511\/NTM-Lung-Disease-What-it-is-and-What-you-Need-to-Know.aspx"},{"key":"e_1_3_3_58_2","unstructured":"American Lung Association. Learn about bronchiectasis. Accessed 15 September 2024. https:\/\/www.lung.org\/lung-health-diseases\/lung-disease-lookup\/bronchiectasis\/learn-about-bronchiectasis"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2021.1987891"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-023-02954-2"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.931876"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI175264"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0055-2019"},{"key":"e_1_3_3_64_2","unstructured":"Cleveland Clinic. Bronchiectasis: Causes symptoms treatment & prevention. Published 2022. Accessed 18 September 2024. https:\/\/www.clevelandclinic.org"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-018-0121-y"},{"key":"e_1_3_3_66_2","unstructured":"Barbosa M Chalmers DJ. Bronchiectasis is a final common pathway of a wide variety of underlying conditions including infectious. Accessed 15 September 2024. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0755498223000118?via=ihub"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.3109\/15412555.2015.1089846"},{"issue":"4","key":"e_1_3_3_68_2","first-page":"1","article-title":"Environmental exposures and lung aging: Molecular mechanisms and implications for improving respiratory health","volume":"8","author":"Eckhardt CM","year":"2021","unstructured":"Eckhardt CM, Wu H. Environmental exposures and lung aging: Molecular mechanisms and implications for improving respiratory health. Curr Environ Health Rep. 2021;8(4):1\u201313.","journal-title":"Curr Environ Health Rep."},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2018.10.002"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2015.01.023"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1136\/oem.2006.027995"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1097\/EE9.0000000000000271"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01957"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.14060"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0057-2018"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.4103\/0970-2113.80321"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.03357"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pulmoe.2018.09.006"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2019.03.013"},{"issue":"3","key":"e_1_3_3_80_2","first-page":"273","article-title":"Pulmonary hypertension and chronic cor pulmonale in COPD","volume":"2","author":"Shujaat A","year":"2007","unstructured":"Shujaat A, Minkin R, Eden E. Pulmonary hypertension and chronic cor pulmonale in COPD. Int J Chron Obstruct Pulmon Dis. 2007;2(3):273\u2013282. https:\/\/pubmed.ncbi.nlm.nih.gov\/18229565\/","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1513\/pats.201101-008MW"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2017.11.024"},{"key":"e_1_3_3_83_2","unstructured":"Klabunde RE. Beta-adrenoceptor agonists (\u03b2-agonists). Published 2024. Accessed 18 September 2024. https:\/\/cvpharmacology.com\/cardiostimulatory\/beta-agonist"},{"issue":"2","key":"e_1_3_3_84_2","first-page":"343","article-title":"\u03b2-Adrenergic receptor, an essential target in cardiovascular diseases","volume":"25","author":"Chikere Ali D","year":"2019","unstructured":"Chikere Ali D, Naveed M, Gordon A, et al. \u03b2-Adrenergic receptor, an essential target in cardiovascular diseases. Heart Fail Rev. 2019;25(2):343\u2013354. https:\/\/pubmed.ncbi.nlm.nih.gov\/31407140\/","journal-title":"Heart Fail Rev."},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-23274-9_13"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2021\/e2420"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12196417"},{"key":"e_1_3_3_88_2","doi-asserted-by":"crossref","unstructured":"Angel Martinez-Garcia M Miravitlles M. Bronchiectasis in COPD patients: More than a comorbidity? Published 2017. Accessed 19 September 2024. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5436792\/pdf\/copd-12-1401.pdf","DOI":"10.2147\/COPD.S132961"},{"issue":"25","key":"e_1_3_3_89_2","first-page":"434","article-title":"The diagnosis and treatment of COPD and its comorbidities","volume":"120","author":"Kahnert K","year":"2023","unstructured":"Kahnert K, J\u00f6rres RA, Behr J, Welte T. The diagnosis and treatment of COPD and its comorbidities. Dtsch Arztebl Int. 2023;120(25):434\u2013444. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10478768\/","journal-title":"Dtsch Arztebl Int."},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202308-1468VP"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00629-2017"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcl.2008.11.006"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12196417"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202108-1889OC"},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202402-0314ED"},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00080312"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.1590\/0100-3984.2015.0146"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212463"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.1067\/j.cpradiol.2017.12.001"},{"issue":"5","key":"e_1_3_3_100_2","first-page":"384","article-title":"COPDGene\u00ae 2019: Redefining the diagnosis of chronic obstructive pulmonary disease","volume":"6","author":"Lowe KE","year":"2019","unstructured":"Lowe KE, Regan EA, Anzueto A, et al. COPDGene\u00ae 2019: Redefining the diagnosis of chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis. 2019;6(5):384\u2013399. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7020846\/","journal-title":"Chronic Obstr Pulm Dis."},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.1177\/2045894019894531"},{"key":"e_1_3_3_102_2","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S378642"},{"issue":"1","key":"e_1_3_3_103_2","article-title":"Update: Non-invasive ventilation in chronic obstructive pulmonary disease","volume":"10","author":"Shah NM","year":"2018","unstructured":"Shah NM, D\u2019Cruz RF, Murphy PB. Update: Non-invasive ventilation in chronic obstructive pulmonary disease. J Thorac Dis. 2018;10(Suppl 1):S71\u2013S79.","journal-title":"J Thorac Dis."},{"issue":"5","key":"e_1_3_3_104_2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4103\/ijccm.IJCCM_474_17","article-title":"Noninvasive ventilation for acute respiratory failure due to noncystic fibrosis bronchiectasis","volume":"22","author":"Hadda V","year":"2018","unstructured":"Hadda V, Chawla G, Tiwari P, et al. Noninvasive ventilation for acute respiratory failure due to noncystic fibrosis bronchiectasis. Indian J Crit Care Med. 2018;22(5):326\u2013331. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5971640\/","journal-title":"Indian J Crit Care Med."},{"key":"e_1_3_3_105_2","doi-asserted-by":"publisher","DOI":"10.4046\/trd.2023.0010"},{"key":"e_1_3_3_106_2","unstructured":"Insmed. New England Journal of Medicine Publishes positive results from Phase 2 WILLOW study of brensocatib in patients with non-cystic fibrosis bronchiectasis. Accessed 20 September 2024. https:\/\/investor.insmed.com\/2020-09-07-New-England-Journal-of-Medicine-Publishes-Positive-Results-from-Phase-2-WILLOW-Study-of-Brensocatib-in-Patients-with-Non-Cystic-Fibrosis-Bronchiectasis"},{"key":"e_1_3_3_107_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13665-014-0084-2"},{"key":"e_1_3_3_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.04.029"},{"key":"e_1_3_3_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.07.013"},{"key":"e_1_3_3_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2020.05.006"},{"issue":"4","key":"e_1_3_3_111_2","first-page":"875","article-title":"The effect of inhaled corticosteroids on pneumonia risk in patients with COPD-bronchiectasis overlap: A UK population-based case-control study","volume":"164","author":"Ritchie A","year":"2023","unstructured":"Ritchie A, Singanayagam A, Mitchell S, et al. The effect of inhaled corticosteroids on pneumonia risk in patients with COPD-bronchiectasis overlap: A UK population-based case-control study. Amer Coll Chest Physic. 2023;164(4):875\u2013884. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0012369223008085","journal-title":"Amer Coll Chest Physic."},{"key":"e_1_3_3_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e12620"},{"key":"e_1_3_3_113_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.1937"},{"key":"e_1_3_3_114_2","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S292297"},{"key":"e_1_3_3_115_2","doi-asserted-by":"publisher","DOI":"10.4046\/trd.2018.0030"},{"key":"e_1_3_3_116_2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0141-2022"},{"key":"e_1_3_3_117_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.518345"},{"issue":"5","key":"e_1_3_3_118_2","article-title":"Inhaled corticosteroids for bronchiectasis","volume":"5","author":"Kapur N","year":"2018","unstructured":"Kapur N, Petsky HL, Bell S, et al. Inhaled corticosteroids for bronchiectasis. Cochrane Database Syst Rev. 2018;5(5).","journal-title":"Cochrane Database Syst Rev."},{"key":"e_1_3_3_119_2","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.03.116"},{"key":"e_1_3_3_120_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01133-w"},{"key":"e_1_3_3_121_2","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.06384"},{"issue":"5","key":"e_1_3_3_122_2","article-title":"Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease","volume":"2017","author":"Janjua S","year":"2020","unstructured":"Janjua S, Fortescue R, Poole P. Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2020;2017(5):CD002309.","journal-title":"Cochrane Database Syst Rev."},{"issue":"5","key":"e_1_3_3_123_2","article-title":"Mucolytics for bronchiectasis","volume":"2014","author":"Wilkinson M","year":"2014","unstructured":"Wilkinson M, Sugumar K, Milan SJ, et al. Mucolytics for bronchiectasis. Cochrane Database Syst Rev. 2014;2014(5).","journal-title":"Cochrane Database Syst Rev."},{"key":"e_1_3_3_124_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.160830"},{"key":"e_1_3_3_125_2","doi-asserted-by":"publisher","DOI":"10.1186\/2110-5820-1-14"},{"key":"e_1_3_3_126_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030804"},{"key":"e_1_3_3_127_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00208011"},{"key":"e_1_3_3_128_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv121"},{"issue":"12","key":"e_1_3_3_129_2","first-page":"175346581775052","article-title":"Defining the relationship between COPD and CVD: What are the implications for clinical practice?","volume":"12","author":"Morgan AD","year":"2018","unstructured":"Morgan AD, Zakeri R, Quint JK. Defining the relationship between COPD and CVD: What are the implications for clinical practice? Ther Adv Respir Dis. 2018;12(12):175346581775052. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5937157\/","journal-title":"Ther Adv Respir Dis."},{"key":"e_1_3_3_130_2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-211553"},{"key":"e_1_3_3_131_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41533-017-0040-z","article-title":"Determinants of initial inhaled corticosteroid use in patients with GOLD A\/B COPD: A retrospective study of UK general practice","volume":"27","author":"Chalmers JD","year":"2017","unstructured":"Chalmers JD, Tebboth A, Gayle A, et al. Determinants of initial inhaled corticosteroid use in patients with GOLD A\/B COPD: A retrospective study of UK general practice. NPJ Prim Care Respir Med. 2017;27(1). https:\/\/www.nature.com\/articles\/s41533-017-0040-z","journal-title":"NPJ Prim Care Respir Med."},{"key":"e_1_3_3_132_2","doi-asserted-by":"publisher","DOI":"10.4103\/0970-2113.184874"},{"key":"e_1_3_3_133_2","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S156126"},{"key":"e_1_3_3_134_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01127-2017"},{"key":"e_1_3_3_135_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfda.2018.12.006"},{"key":"e_1_3_3_136_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70185-7"}],"container-title":["Therapeutic Advances in Pulmonary and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29768675241300808","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/29768675241300808","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29768675241300808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:48:09Z","timestamp":1777394889000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/29768675241300808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":135,"alternative-id":["10.1177\/29768675241300808"],"URL":"https:\/\/doi.org\/10.1177\/29768675241300808","relation":{},"ISSN":["2976-8675","2976-8675"],"issn-type":[{"value":"2976-8675","type":"print"},{"value":"2976-8675","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]},"article-number":"29768675241300808"}}